Late Phase Clinical Trials

Refine--and redefine--research objectives at registration and beyond 

With Quintiles as your partner, you can address ever-evolving post-market environments with ease. We can help you develop and implement strategies to meet increasing stakeholder requirements and position your product for better market access, expanded labeling and more.

promo_men talking

Quintiles has delivered more than 530 Real-World & Late Phase Programs involving more than 74,000 sites and more than 650,000 enrolled patients in more than 100 countries since 2011.

Adapt to a rapidly changing post-market climate

Quintiles Scientific Affairs: The right choice for real-world scientific expertise

Regulatory agencies increasingly call for more data past market approval. Payers are tightening reimbursement criteria. Without an agile post-marketing strategy, your investment may not reap its full value.

Optimize your product’s potential

Monitor safety and comply with regulatory commitments, position your product for better market access, and demonstrate efficacy or comparative effectiveness with assistance from Quintiles' global network of late phase clinical trial specialists.
  • Global capabilities and site network poised to ramp up for large trials quickly and efficiently.
  • Scientific affairs teams – epidemiologists, biostatisticians, pharmacists, health economists and clinicians – ready to assist in developing scientific concepts and study protocols.
  • Experts in all major therapeutic and medical practice areas to provide valuable insight and support for new indications or label extensions.

Proof in marketplace

There's no obstacle too big (or small) in late phase clinical trials.

Related Services

Between March 2011 and March 2012, Quintiles processed 267K+ safety cases at an on-time rate of 99%. Additionally, 59K+ cases were reported to regulatory authorities with 99.8% on-time compliance.
Quintiles has engaged with more than 2,500 hospitals participating in the AHA's Get with The Guidelines program.
Quintiles has access to more than 18M patient lives from hospital data in the COMPASS network